Skip to Content
Merck

HPLC Analysis of Cetuximab Antibody Fragments from Papain Digestion on Zenix® SEC-150

HPLC Analysis of Cetuximab Antibody Fragments from Papain Digestion on Zenix® SEC-150 application for HPLC

Materials

analytical column

Product No.
Description
Pricing

Zenix® SEC-150 Gel Filtration Column, 3 μm

L × I.D. 30 cm × 7.8 mm, 3 μm particle size, stainless steel

CONDITIONS

column

Zenix SEC-150, 30 cm x 7.8 mm I.D., 3 μm, 150 Å particles (Z777018)

mobile phase

20 mM sodium phosphate, pH 7.0, 150 mM NaCl

flow rate

1.0 mL/min

column temp.

25 °C

detector

UV, 280 nm

injection

10 μL

sample

Cetuximab ERBITUX®, papain digest

Description

Other Notes

Papain digestion conditions: Buffer: 5.0 mM L-Cysteine, 2.0 mM EDTA and 300 mM NaCl; Enzyme: 80 μg/mL papain; Temperature: 37 °C; Time: 30 min, 60 min, 120 min, 240 min, and 360 min.

Legal Information

Erbitux is a registered trademark of Eli Lilly and Co.
Zenix is a registered trademark of Sepax Technologies